R&D Reinforcement A continued increase in R&D investment (9.1% of sales invested) More than 900 new drugs on the pipeline stage
The Korean pharmaceutical industry continues to expand its investment in R&D each year to boost the development of new medicines. Korean pharmaceutical companies have more than 900 new medicines currently in the pipeline and this number accounts for 4% of the total pipelines in the world.More Detail
Biopharmaceuticals Developed the world's first stem-cell therapy product Producing four of seven globally commercialized stem-cell therapy products
Korea is rising as a global biopharmaceutical power based on its outstanding biotechnology infrastructure, advanced clinical study, and world-class IT technology.More Detail
Globalization Exports reaching USD 3.1 billion Increased export of technology transfer
The Korean pharmaceutical industry is advancing into the world in earnest as evidenced by its increasing export of finished products, drug substances, and technology.
The total exports of pharmaceutical products sold in 188 countries in 2016 stand at USD 3.12 billion, a 6% increase from the previous year. As for the technology transfer, 8 cases of technology exports were made in 2017 alone which amounts to USD 1.23 billion.